STM-416

· SURGE Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for STM-416, covering 2026-02-19 to 2026-02-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer [Phase 1, Phase 2]